144 related articles for article (PubMed ID: 8732703)
1. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study.
Chaturvedi N; Stephenson JM; Fuller JH
Diabetes Care; 1996 May; 19(5):423-30. PubMed ID: 8732703
[TBL] [Abstract][Full Text] [Related]
2. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
Chaturvedi N; Stephenson JM; Fuller JH
Diabetes Care; 1995 Jun; 18(6):785-92. PubMed ID: 7555504
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
Mattock MB; Cronin N; Cavallo-Perin P; Idzior-Walus B; Penno G; Bandinelli S; Standl E; Kofinis A; Fuller JH;
Diabet Med; 2001 Jan; 18(1):59-67. PubMed ID: 11168343
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH;
Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group.
Koivisto VA; Stevens LK; Mattock M; Ebeling P; Muggeo M; Stephenson J; Idzior-Walus B
Diabetes Care; 1996 Jul; 19(7):689-97. PubMed ID: 8799621
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
[TBL] [Abstract][Full Text] [Related]
7. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
Davies L; Fulcher GR; Atkins A; Frumar K; Monaghan J; Stokes G; Clifton-Bligh P; McElduff A; Robinson B; Stiel J; Twigg S; Wilmshurst E
J Diabetes Complications; 1999; 13(1):45-51. PubMed ID: 10232709
[TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
[TBL] [Abstract][Full Text] [Related]
11. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study.
Kempler P; Tesfaye S; Chaturvedi N; Stevens LK; Webb DJ; Eaton S; Kerényi Z; Tamás G; Ward JD; Fuller JH;
Diabet Med; 2002 Nov; 19(11):900-9. PubMed ID: 12421426
[TBL] [Abstract][Full Text] [Related]
12. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
[TBL] [Abstract][Full Text] [Related]
13. A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study.
Lloyd CE; Stephenson J; Fuller JH; Orchard TJ
Diabetes Care; 1996 Mar; 19(3):219-25. PubMed ID: 8742565
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
[TBL] [Abstract][Full Text] [Related]
15. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
Savage S; Estacio RO; Jeffers B; Schrier RW
Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388
[TBL] [Abstract][Full Text] [Related]
16. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.
Veglio M; Borra M; Stevens LK; Fuller JH; Perin PC
Diabetologia; 1999 Jan; 42(1):68-75. PubMed ID: 10027581
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Schmidt AM; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
Soedamah-Muthu SS; Chaturvedi N; Toeller M; Ferriss B; Reboldi P; Michel G; Manes C; Fuller JH;
Diabetes Care; 2004 Feb; 27(2):530-7. PubMed ID: 14747240
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control.
De Pablos PL; Martinez J; Martinez MP; Doreste JA
Diabetes Metab; 1998 Sep; 24(4):337-43. PubMed ID: 9805644
[TBL] [Abstract][Full Text] [Related]
20. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J
Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
